GH

Guardant Health Stock Analysis

AI Rating

Low
  • Quality1/10
  • Growth 5/10
  • Value 0/10
Guardant Health sales and earnings growth
GH Growth
Neutral
  • Revenue Y/Y 31.32%
  • EPS Y/Y 0.00%
  • FCF Y/Y 22.22%
Guardant Health gross and profit margin trends
GH Profitability
Neutral
  • Gross margin 64.90%
  • EPS margin -40.10%
  • ROIC 5Y -22.40%
Guardant Health net debt vs free cash flow
GH Risk
Great
  • Debt / Equity 0.0
  • Debt / FCF 2.4
  • Interest coverage -96.5

Guardant Health stock volatility is in-line with the overall market. We give it a Great risk rating.

↗ More Diagnostics & Research stocks